home / stock / abos / abos short
Short Information | Acumen Pharmaceuticals Inc. (NASDAQ:ABOS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,632,686 |
Total Actual Volume | 13,247,299 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 81,634 |
Average Short Percentage | 18.68% |
Is there a ABOS Short Squeeze or Breakout about to happen?
See the ABOS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $2.39 | $2.31 | $2.39 | $2.26 | 263,211 | 59,880 | 22.75% |
07-03-2024 | $2.29 | $2.37 | $2.37 | $2.24 | 186,108 | 44,347 | 23.83% |
07-02-2024 | $2.38 | $2.27 | $2.4 | $2.23 | 276,644 | 67,802 | 24.51% |
07-01-2024 | $2.4 | $2.385 | $2.48 | $2.325 | 340,074 | 76,513 | 22.5% |
06-28-2024 | $2.33 | $2.42 | $2.51 | $2.33 | 5,515,723 | 100,611 | 1.82% |
06-27-2024 | $2.22 | $2.36 | $2.53 | $2.22 | 958,434 | 158,729 | 16.56% |
06-26-2024 | $2.13 | $2.16 | $2.265 | $2.08 | 723,963 | 169,782 | 23.45% |
06-25-2024 | $2.25 | $2.14 | $2.285 | $2.14 | 432,557 | 117,371 | 27.13% |
06-24-2024 | $2.31 | $2.24 | $2.385 | $2.2 | 414,582 | 88,268 | 21.29% |
06-21-2024 | $2.23 | $2.31 | $2.32 | $2.2 | 421,435 | 52,382 | 12.43% |
06-20-2024 | $2.33 | $2.21 | $2.36 | $2.17 | 475,262 | 65,064 | 13.69% |
06-18-2024 | $2.49 | $2.33 | $2.5 | $2.33 | 408,589 | 74,365 | 18.2% |
06-17-2024 | $2.65 | $2.5 | $2.65 | $2.48 | 276,221 | 62,904 | 22.77% |
06-14-2024 | $2.63 | $2.64 | $2.66 | $2.57 | 205,119 | 26,062 | 12.71% |
06-13-2024 | $2.66 | $2.64 | $2.78 | $2.59 | 399,517 | 79,047 | 19.79% |
06-12-2024 | $2.72 | $2.7 | $2.745 | $2.64 | 238,181 | 30,198 | 12.68% |
06-11-2024 | $2.58 | $2.65 | $2.735 | $2.57 | 336,248 | 37,788 | 11.24% |
06-10-2024 | $2.6 | $2.62 | $2.635 | $2.52 | 269,856 | 43,992 | 16.3% |
06-07-2024 | $2.44 | $2.62 | $2.63 | $2.44 | 497,854 | 114,845 | 23.07% |
06-06-2024 | $2.6 | $2.49 | $2.67 | $2.46 | 607,721 | 162,736 | 26.78% |
News, Short Squeeze, Breakout and More Instantly...
Acumen Pharmaceuticals Inc. Company Name:
ABOS Stock Symbol:
NASDAQ Market:
Acumen Pharmaceuticals Inc. Website:
Announced initiation of ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in May 2024 Initiation of a Phase 1 study to support a subcutaneous dosing option of sabirnetug expected in mid-2024 Cash, cash equivalent...
CHARLOTTESVILLE, Va., May 13, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that...
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that...